Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–35
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary informed consent form and has received signed and dated copy of the informed consent form
Male participants; age between 18 to 35 years, inclusive
Well trained endurance cyclist (competing at a minimum of Category 3 road-racing/estimated 10 mile TT of \<23 minutes), with a training history \>1 year
Good general and mental health
You may not be if
Currently taking any nutritional supplements, polyphenols or beta-blockers, Non-steroidal anti-inflammatory drugs (NSAIDs), recreational drugs
Known or suspected intolerance or hypersensitivity to the study material or any of their stated ingredients
Allergy to milk or wheat products
Heart or any other medical condition that may contra-indicate participants from taking part in high intensity or exhaustive physical activity
Previous participation in this study; another clinical study or receipt of an investigational drug within 30 days of the screening visit; participation in another study involving a protocol to elicit Exercise-Induced Muscle Damage (EIMD) within 6 months of the screening visit
Clareo Health | Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent Exercise
